Bolt Biotherapeutics, Inc. — Form D

Bolt Biotherapeutics, Inc. of REDWOOD CITY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-07-15. The offering totals $40.1M, of which $40.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
Edgar EnglemanExecutive OfficerPalo Alto, CA
David DornanExecutive OfficerMORRISTOWN, NJ
Edgar EnglemanDirectorPalo Alto, CA
WILLIAM QUINNExecutive OfficerMorgantown, WV
James HealyDirectorSunnyvale, CA
Mahendra ShahDirectorPalo Alto, CA
Richard MillerDirectorWaxahachie, TX
Peter MoldtDirectorSeattle, WA
Reiner LausDirectorSan Diego, CA
Reiner LausExecutive OfficerSan Diego, CA
Ashish KhannaDirectorSouth San Francisco, CA
Chih-Ping LiuDirectorPortola Valley, CA
Chih-Ping LiuExecutive OfficerPortola Valley, CA
Chih-Ping LiuPromoterPortola Valley, CA
Edith PerezExecutive OfficerRedwood City, CA
Grant YonehiroExecutive OfficerRedwood City, CA
Kathleen LaPorteDirectorRedwood City, CA
Randall SchatzmanDirectorSeattle, WA
Randall SchatzmanExecutive OfficerSeattle, WA
Ashish G KhannaDirectorRedwood City, CA
Grant G YonehiroExecutive OfficerRedwood City, CA
Peter G MoldtDirectorRedwood City, CA
Ken G HarrisonDirectorRedwood City, CA
Peter G BisgaardDirectorPleasanton, CA
Mahendra G ShahDirectorTURKU, H9

Other filings by this issuer (6)

FiledFormOfferingSold
2021-06-07D$15.0M$15.0M
2021-01-28D$93.5M$93.5M
2018-08-06D$13.4M$13.4M
2018-02-20D$6.0M$6.0M
2016-09-30D$16.0M$10.0M
2015-05-07D$800K$600K

More